HUTCHMED (China) Limited
HCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $630,201 | $837,999 | $426,409 | $356,128 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | $348,884 | $384,447 | $311,103 | $258,234 |
| Gross Profit | $281,317 | $453,552 | $115,306 | $97,894 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| R&D Expenses | $213,365 | $303,055 | $267,587 | $207,447 |
| G&A Expenses | $64,296 | $79,784 | $92,173 | $89,298 |
| SG&A Expenses | $112,913 | $133,176 | $136,106 | $127,125 |
| Sales & Mktg Exp. | $48,617 | $53,392 | $43,933 | $37,827 |
| Other Operating Expenses | -$4,351 | $0 | $119,306 | $91,639 |
| Operating Expenses | $321,927 | $436,231 | $522,999 | $426,211 |
| Operating Income | -$43,705 | $18,375 | -$409,770 | -$344,288 |
| % Margin | -6.9% | 2.2% | -96.1% | -96.7% |
| Other Income/Exp. Net | $89,067 | $87,228 | $51,519 | $188,959 |
| Pre-Tax Income | $45,362 | $105,603 | -$360,240 | -$155,329 |
| Tax Expense | $7,192 | $4,509 | -$283 | $11,918 |
| Net Income | $37,729 | $100,780 | -$360,835 | -$194,648 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.22 | 0.6 | -2.15 | -1.25 |
| % Growth | -63.3% | 127.9% | -72% | – |
| EPS Diluted | 0.22 | 0.6 | -2.15 | -1.25 |
| Weighted Avg Shares Out | 171,070 | 169,931 | 169,429 | 158,537 |
| Weighted Avg Shares Out Dil | 174,566 | 173,839 | 169,429 | 158,537 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40,080 | $36,145 | $9,599 | $2,076 |
| Interest Expense | $2,872 | $759 | $652 | $592 |
| Depreciation & Amortization | $12,341 | $8,207 | $8,664 | $7,190 |
| EBITDA | $14,106 | $67,274 | -$401,106 | -$207,958 |
| % Margin | 2.2% | 8% | -94.1% | -58.4% |